02 November 2017 1 Min Read
STOCK OFFER
Ascendis seeks R750m capital injection
The pharmaceuticals and health products group plans to price new shares at a premium, saying its existing shares are undervalued
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In